Navigation Links
Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
Date:12/5/2008

parting group, for their extensive contributions to Orexigen. We believe we are in a very favorable position largely as a result of their efforts."

The Company is directing all of its efforts and resources to Contrave(R) and Empatic(TM), its obesity product candidates. It anticipates announcing the results from the first Phase 3 clinical trial for Contrave in January.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead combination product candidates are Contrave, which is in Phase 3 clinical trials, and Empatic, which is in the later stages of Phase 2 clinical development. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the company can be found at http://www.orexigen.com.

Forward-Looking Statements

Orexigen cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "indicates," "will," "intends," "potential," "suggests," "assuming," "designed" and similar expressions are intended to identify forward-looking statements. These statements are based on the Company's current beliefs and expectations. These forward-looking statements include statements regarding the objectives of the Company's organizational changes, the enrollment, timing, execution, completion and announcement of results of clinical trials of Contrave and the potential to obtain regulatory approval for, and effectively treat obesity with its product candidates. The inclusion of forward-looking statements should not be regarded as a representation by Orexigen that any of its plans
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ROCHESTER, N.Y. , Sept. 3, 2015 /PRNewswire/ ... provider of clinical trial imaging solutions, announced today, ... providing support for a new philanthropic, epidemiology study ... Africa .  VirtualScopics has teamed up ... children in Zambia.  The image results will be ...
(Date:9/3/2015)... YORK , Sept. 3, 2015  The findings ... are raising disturbing questions about the company,s handling of ... LLP reports.  On September 2 nd , part ... 300 adverse events, including at least 27 fatalities, have ... disclosed a confidential study commissioned by C.R. Bard in ...
(Date:9/3/2015)... DUBLIN , Sept. 3, 2015 Research ... of the "Investigation Report on China Olmesartan Market, ... In 1991, olmesartan medoxomil was successfully developed by Sankyo ... In Apr. 2002, olmesartan medoxomil was approved by FDA ... now become the best- selling drug in the world ...
Breaking Medicine Technology:VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 4IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3China Olmesartan Investigation Market Report 2010-2019 2
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Friday night, ... IL hosting Generation Rescue’s A Night of Hope event supporting families affected by autism, ... and Rowena and Joe Salas, joined together at the Oscar Swan Inn to support ...
(Date:9/3/2015)... CA (PRWEB) , ... September 03, 2015 , ... TransPack ... X. Users can choose from wipes and framing transitions in 30 different styles. ... made exclusively for Final Cut Pro X. , TransPack Toon features 90 cartoon transitions ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... agreement with Amerinet Inc., a leading national healthcare solutions organization, to provide electronic ... EMR. , Through this agreement, Amerinet members will receive negotiated pricing on E-Volve ...
(Date:9/3/2015)... ... September 03, 2015 , ... DriButts, a non-profit organization dedicated ... Product Development Group to manufacture a long-lasting reusable diaper for warm weather climates ... to bring 600 DriButts Diapers to rural areas of Haiti during a trip ...
(Date:9/3/2015)... ... 2015 , ... Silverado next week lays the foundation on ... Bellingham, Washington. Silverado Bellingham, a 41,000 square foot, single-story community, is expected to ... 80 people living with Alzheimer’s, dementia and other memory-impairing conditions. , Site ...
Breaking Medicine News(10 mins):Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2
... , , WASHINGTON, July 13 ... society of blood specialists, will honor six scientists who have made ... the newly created Ernest Beutler Lecture and Prize, will be presented ... New Orleans. , , ...
... , ALEXANDRIA, Va., July 13 The nation,s hospice providers ... billion over a ten-year period in the preliminary estimates of the House ... Office. , , These cuts are ... 1 as a result of the elimination of the Budget Neutrality Adjustment ...
... Consumption also appears to undercut effect of cancer-prevention drug, ... especially when it,s beer, increases the risk for highly ... The researchers did not set out to determine the ... rather to test the effectiveness of finasteride (Proscar, Propecia), ...
... than 10 years, the universally accepted lung cancer staging system ... patients with non-small cell lung cancer (NSCLC). A ... the peer-reviewed journal of the American College of Chest Physicians ... Staging Committee of the International Association for the Study of ...
... laws restricting the ability of hospitals to disclose patient ... suffer by more than 24%, according to the Management ... Science , the flagship journal of the Institute for ... drop is seen most clearly in reduced adoption of ...
... you could test your risk for Alzheimer,s disease much like ... UCLA scientists have discovered a way to measure the ... cells in the blood. Amyloid beta forms the plaques considered ... isn,t adequately clearing amyloid beta, it may indicate Alzheimer,s risk, ...
Cached Medicine News:Health News:Six Researchers to Receive Prestigious Awards from the American Society of Hematology 2Health News:Six Researchers to Receive Prestigious Awards from the American Society of Hematology 3Health News:More Cuts to Hospice Announced: Hospice Community Responds with Virtual Lobby Day on July 15 2Health News:Heavy Drinking Linked to Aggressive Prostate Cancer 2Health News:Heavy Drinking Linked to Aggressive Prostate Cancer 3Health News:New lung cancer staging system revealed 2Health News:New lung cancer staging system revealed 3Health News:State privacy rules reduce electronic medical sharing by 24 percent, warns Management Insights 2Health News:UCLA scientists identify how immune cells may help predict Alzheimer's risk 2
... Millex Filter Units,Filter units with hydrophobic ... Fluoropore membrane are ideal for the ... of sterile containers, and for sterilizing ... 25 mm Millex filter units are ...
... -4C. 5.5 Cubic Ft. ... light. Manual push button ... Two shelves. In-door shelves ... thermostat. Magnetic gasket. Hermetically ...
... Bottled Water, The Simplicity personal water system ... currently use bottled water. In addition to ... store bottled water, your laboratory applications may ... be absorbed from containers and cause water ...
The incorporation of a reverse osmosis (RO) system and an ultrapure water system into a single stand-alone tower provides numerous benefits to the busy laboratory....
Medicine Products: